Cancerfighter’s Weblog

Alternative cancer therapies and ideas

Intravenous vitamin C therapy – discussion

Posted by Jonathan Chamberlain on May 1, 2008


Courtesy of K.M.

(http://www.orthomol ecular.org/ library/ivccance rpt.shtml)

October 30, 2007

INTRAVENOUS VITAMIN C and CANCER
_http://www.orthomol ecular.org/ library/ivccance rpt.shtml_ (http://www.orthomol ecular.org/ library/ivccance rpt.shtml)

“…it takes much more than logic and clear-cut demonstrations to overcome
the inertia and dogma of established thought.”

— Irving Stone

Irving Stone was an early thinker and writer about vitamin C (its scientific
name is ascorbic acid). He knew it would be an uphill battle to change the
way the medical profession viewed vitamin C. While most doctors accept that
scurvy is a vitamin C deficiency illness, few have made the rather humongous
jump to seeing high dose intravenous vitamin C as a major player in the
management of cancer.

There is actually a wide spectrum of medical uses for vitamin C. Evidence
exists documenting it as the best antiviral agent now available … IF used at
the proper dose. Vitamin C can neutralize and eliminate a wide range of
toxins. Vitamin C will enhance host resistance, greatly augmenting the immune
system’s ability to neutralize bacterial and fungal infections. Now the National
Institutes of Health
has published evidence demonstrating vitamin C’s
anti-cancer properties. With so many medical benefits, why do so few doctors know
of them?

One explanation stems from ascorbic acid’s designation as a “vitamin.”
Consider Dorland’s Illustrated Medical Dictionary’s definition of vitamin: A
general term for a number of unrelated organic substances that occur in many
foods in small amounts that are necessary in trace amounts for the normal
metabolic functioning of the body
. As a vitamin, only a minuscule 60 mg of ascorbic acid is needed to prevent
the emergence of scurvy symptoms. As a medical treatment for cancer and
life-threatening infections and toxic exposures, tens of thousands of milligrams
of ascorbic acid must be administered, often by the intravenous (IV) as well
as the oral route.

The Center’s founder, Dr. Hugh Riordan, was a true scientist who believed in
the power of scientific measurement over dogma. With the establishment of
The Center in 1975, he routinely checked plasma vitamin C levels in chronically
ill patients. He found these sick patients to be consistently low in their
plasma C levels. Interestingly enough, the cancer patients he was seeing had
VERY LOW vitamin C reserves
. This matched scientific literature documenting low vitamin C levels in
cancer patients. Cancer cells were actively taking up vitamin C in a way that
depleted tissue reserves of C.

PET scans are commonly ordered by oncologists to evaluate their cancer
patients for metastases (cancer spread to other organs). What is actually injected
into the patient at the start of the scan is radioactive glucose. Cancer
cells
are anaerobic obligates, which means they depend upon glucose as their
primary source of metabolic fuel. Cancer cells employ transport mechanisms
called glucose transporters to actively pull in glucose.

In the vast majority of animals, vitamin C is synthesized from glucose in
only four metabolic steps. Hence, the molecular shape of vitamin C is
remarkably similar to glucose. (Figure 1) Cancer cells will actively transport vitamin
C into themselves, possibly because they mistake it for glucose. Another
plausible explanation is that they are using the vitamin C as an antioxidant.
Regardless, the vitamin C accumulates in cancer cells.

Figure 1
If large amounts of vitamin C are presented to cancer cells, large amounts
will be absorbed. In these unusually large concentrations, the antioxidant
vitamin C will start behaving as a pro-oxidant as it interacts with
intracellular copper and iron. This chemical interaction produces small amounts of
hydrogen peroxide.

Because cancer cells are relatively low in an intracellular anti-oxidant
enzyme called catalase, the high dose vitamin C induction of peroxide will
continue to build up until it eventually lyses the cancer cell from the inside
out! This effectively makes high dose IVC a non-toxic chemotherapeutic agent
that can be given in conjunction with conventional cancer treatments. Based on
the work of several vitamin C pioneers before him, Dr. Riordan was able to
prove that vitamin C was selectively toxic to cancer cells if given
intravenously. This research was recently reproduced and published by Dr. Mark Levine at
the National Institutes of Health.

As feared by many oncologists, small doses may actually help the cancer
cells
because small amounts of vitamin C may help the cancer cells arm themselves
against the free-radical induced damage caused by chemotherapy and
radiation. Only markedly higher doses of vitamin C will selectively build up as
peroxide in the cancer cells to the point of acting in a manner similar to
chemotherapy. These tumor-toxic dosages can only be obtained by intravenous
administration.

Over a span of 15 years of vitamin C research, Dr. Riordan’s RECNAC (cancer
spelled backwards) research team generated 20 published papers on vitamin C
and cancer. RECNAC even inspired its second cancer research institute, known
as RECNAC II, at the University of Puerto Rico. This group recently published
an excellent paper in Integrative Cancer Therapies, titled “Orthomolecular
Oncology Review: Ascorbic Acid and Cancer 25 Years Later.” RECNAC data has
shown that vitamin C is toxic to tumor cells without sacrificing the performance
of chemotherapy.

Intravenous vitamin C also does more than just kill cancer cells. It boosts
immunity. It can stimulate collagen formation to help the body wall off the
tumor. It inhibits hyaluronidase, an enzyme that tumors use to metastasize and
invade other organs throughout the body. It induces apoptosis to help
program cancer cells into dying early. It corrects the almost universal scurvy in
cancer patients. Cancer patients are tired, listless, bruise easily, and have
a poor appetite. They don’t sleep well and have a low threshold for pain.
This adds up to a very classic picture of scurvy that generally goes
unrecognized by their conventional physicians.

When Center cancer patients receive IVC, they report that their pain level
goes down, and that they are better able to tolerate their chemotherapy. They
bounce back quicker since the IVC reduces the toxicity of the chemotherapy
and radiation without compromising their cancer cell killing effects. IVC is
complementary to oncologic care. IVC is not “either/or” – it’s a good
“both/and” proposition. IVC can help cancer patients withstand the effects of their
traditional therapies, heal faster, be more resilient to infection, develop a
better appetite, and remain more active overall. These things promote a better
response to their cancer therapy.

IVC has been used for three decades here at The Center. There have been no
serious complications, but there are a couple of potential complications that
need to be screened for. Because vitamin C enhances iron absorption, iron
overload must be ruled out. The high sodium load of IVC can create a fluid
overload in a patient with congestive heart failure, renal insufficiency or
failure. We also check our patients for G6PD deficiency (an enzyme used to maintain
stability of the red blood cell membranes). Although many physicians worry
that large doses of vitamin C may cause kidney stones, we have rarely seen the
phenomenon, and several huge clinical trials in the medical literature
refute this misconception.

To summarize, most organisms make their own vitamin C. When they are under
stress, either by illness or injury, Mother Nature has provided them with a
means to facilitate healing: they synthesize more ascorbic acid. As a result,
they are in less pain, they remain active, they can sleep, and they have a
better appetite: all functions which promote healing.

Dr. Riordan once said that here at The Center, we don’t treat cancer… we
treat people who happen to have cancer. IVC is a tool that allows our Center
physicians to harness a healing mechanism that our human ancestors lost long
ago: the ability to dramatically increase tissue levels of vitamin C. Research
shows that the astonishingly high levels achievable only by IVC not only
help fight the risk of infection and the pain of metastases, they actually aid
in the defeat of the cancer cells themselves, through a very elegant mechanism
that does no harm to healthy cells. It’s a discovery that the medical world
is only beginning to discover.

_Ron Hunninghake, M.D.,_ (http://brightspot. org/drs/ronresum e.shtml)
Chief Medical Officer, Olive W. Garvey Center for Healing Arts

2 Responses to “Intravenous vitamin C therapy – discussion”

  1. Carlie Johnson said

    I’m looking for a place that will do Vitamin C infusions in Minnesota. Please forward any info you may have.

    Thanks!

  2. If you want to read a reader’s feedback 🙂 , I rate this post for 4/5. Decent info, but I have to go to that damn yahoo to find the missed bits. Thanks, anyway!

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

 
%d bloggers like this: